Wang HC - Search Results

1

Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study.

Yang FO, Hsu NC, Moi SH, Lu YC, Hsieh CM, Chang KJ, Chen DR, Tu CW, Wang HC, Hou MF. Yang FO, et al. Among authors: wang hc. Asia Pac J Clin Oncol. 2018 Jun;14(3):198-203. doi: 10.1111/ajco.12771. Epub 2017 Oct 18. Asia Pac J Clin Oncol. 2018. PMID: 29045014

2

Detecting breast cancer in mammographically dense breasts: comparing technetium-99m tetrofosmin mammoscintigraphy and ultrasonography.

Wang HC, Chen DR, Kao CH, Lin CC, Lee CC. Wang HC, et al. Cancer Invest. 2002;20(7-8):932-8. doi: 10.1081/cnv-120005907. Cancer Invest. 2002. PMID: 12449724

3

Expression of rTSbeta as a 5-fluorouracil resistance marker in patients with primary breast cancer.

Kuo SJ, Wang HC, Chow KC, Chiou SH, Chiang SF, Lin TY, Chiang IP, Chen DR. Kuo SJ, et al. Among authors: wang hc. Oncol Rep. 2008 Apr;19(4):881-8. Oncol Rep. 2008. PMID: 18357371

4

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

Lu YS, Chen DR, Tseng LM, Yeh DC, Chen ST, Hsieh CM, Wang HC, Yeh HT, Kuo SH, Huang CS. Lu YS, et al. Among authors: wang hc. Cancer Chemother Pharmacol. 2011 Jun;67(6):1257-63. doi: 10.1007/s00280-010-1401-2. Epub 2010 Aug 11. Cancer Chemother Pharmacol. 2011. PMID: 20700740 Clinical Trial.

5

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.

Lin C, Chen DR, Chang KJ, Chang TW, Wang HC. Lin C, et al. Among authors: wang hc. Cancer Chemother Pharmacol. 2012 May;69(5):1363-8. doi: 10.1007/s00280-012-1841-y. Epub 2012 Feb 19. Cancer Chemother Pharmacol. 2012. PMID: 22349922 Clinical Trial.

6

Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy.

Lin PH, Yeh MH, Liu LC, Chen CJ, Tsui YC, Su CH, Wang HC, Liang JA, Chang HW, Wu HS, Yeh SP, Li LY, Chiu CF. Lin PH, et al. Among authors: wang hc. J Surg Oncol. 2013 Nov;108(6):352-7. doi: 10.1002/jso.23403. Epub 2013 Aug 31. J Surg Oncol. 2013. PMID: 23996583

7

Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid.

Chao TC, Chen DR, Chao TY, Chen SC, Yeh DC, Wang HC, Huang WT, Rau KM, Chang KJ, Yang TL, Lee KD, Tai CJ, Tseng LM, Hou MF. Chao TC, et al. Among authors: wang hc. Anticancer Res. 2013 Dec;33(12):5543-7. Anticancer Res. 2013. PMID: 24324095

8

EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.

Yeh DC, Chen DR, Chao TY, Chen SC, Wang HC, Rau KM, Feng YH, Chang YC, Lee KD, Ou-Yang F, Kuo WH, Chang KJ, Lin YC, Tseng LM, Hou MF. Yeh DC, et al. Among authors: wang hc. In Vivo. 2014 Sep-Oct;28(5):1001-4. In Vivo. 2014. PMID: 25189922 Clinical Trial.

9

Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.

Lien MY, Liu LC, Wang HC, Yeh MH, Chen CJ, Yeh SP, Bai LY, Liao YM, Lin CY, Hsieh CY, Lin CC, Li LY, Lin PH, Chiu CF. Lien MY, et al. Among authors: wang hc. Anticancer Res. 2014 Dec;34(12):7319-26. Anticancer Res. 2014. PMID: 25503167 Clinical Trial.

10

Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer.

Lu YC, Ou-Yang FU, Hsieh CM, Chang KJ, Chen DR, Tu CW, Wang HC, Hou MF. Lu YC, et al. Among authors: wang hc. In Vivo. 2016 Mar-Apr;30(2):159-63. In Vivo. 2016. PMID: 26912829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,203 results

Search Page

Filters